<unk> , also known as Bancovid, is a COVID-19 vaccine candidate developed by a Bangladeshi pharmaceutical company Globe Biotech Limited. The vaccine was initially called Bancovid. On 23 November 2021, Globe Biotech has received ethical authorization from the Bangladesh Medical Research Council to conduct the first human trial.
Bangavax
Titermax
Ciltacabtagene autoleucel
Tezacaftor
Corbevax
Tebentafusp
Nalmefene
Pretomanid